Skip to content

Gait Modification for Knee Osteoarthritis

Foot Progression Angle Modification: an Exploratory Six-week Intervention in People With Knee Osteoarthritis

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04323969
Acronym
SENSMOD
Enrollment
3
Registered
2020-03-27
Start date
2020-02-20
Completion date
2020-03-12
Last updated
2020-10-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis, Knee

Keywords

Gait Modification, Wearable Sensors

Brief summary

This randomized clinical trial will compare the changes in performance, biomechanical and clinical outcomes before and after a six-week gait modification intervention. Participants with knee osteoarthritis will attend in-lab assessments and practice, while also performing daily, at-home walking tracked using a custom sensorized shoe.

Detailed description

Greater toe-in or toe-out angles during walking are potential biomechanical management strategies for medial compartment knee osteoarthritis (OA). Multi-week clinical trials demonstrate the biomechanical efficacy and potential clinical efficacy. However, walking biomechanics have only been assessed within laboratory environments and performance of the modifications during daily at-home walking is currently unknown. Furthermore, the modifications have largely been instructed using a specific target, requiring motor learning. No study has examined whether a self-directed strategy is feasible and will produce significant improvements in biomechanical and clinical outcomes. Moreover, objective real-world performance of these modifications is unknown and may explain the previous inconsistent clinical results. This study will address these gaps. The investigators hypothesize that real-world performance of the modifications will improve over the intervention and that both groups will exhibit improvements in biomechanical and clinical outcomes at follow up.

Interventions

BEHAVIORALSpecific Modification Target

Participants will be instructed to increase their baseline foot progression angle by 15 degrees. Visual feedback during practice will be delivered using a mirror and guideline (tape placed on mirror). Verbal feedback will be incorporated to encourage participants to perform the modified foot progression angle as accurately as possible.

BEHAVIORALSelf-directed Modification

Participants will be instructed to modify their foot progression angle as much as is comfortable. A mirror will be used during practice for visual feedback, but no specific target or guide will be provided.

Sponsors

University of British Columbia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Be 50 years of age or greater * Exhibit signs of tibiofemoral OA (a score of ≥ 2 on the Kellgren and Lawrence (KL) grading scale) predominantly in the medial compartment, * Self-reported knee pain ≥ 3 / 10 on a numerical rating scale of pain (NRS; 0 = no pain and 10 = worst pain imaginable) during most days of the previous month * Are comfortable walking intermittently for 30 minutes * Fit into the available sizes of sensorized shoes (sizes spanning US women's 5 to men's 13) * Exhibit at least a 5% reduction in knee adduction moment impulse for 10 degrees of change to foot rotation measured during a screening appointment.

Exclusion criteria

* Any knee surgery or intraarticular injections within the past 6 months * A history of joint replacement surgery or high tibial osteotomy * Current or recent (within 6 weeks) corticosteroid injections * Use of a gait aid * Currently on a wait list for joint replacement surgery or high tibial osteotomy * Any inflammatory arthritic condition * Any other conditions that may affect normal gait or participation in an aerobic exercise program * Cannot attend all required appointments.

Design outcomes

Primary

MeasureTime frameDescription
Change in baseline to week 7 foot rotation angle error during stance - in lab walkingBaseline, Week 7Foot rotation is the specific walking parameter that will be modified during the intervention. It is defined as the angle between the long axis of the foot (heel to toe) and the walking direction. Foot rotation will be measured via standard marker-based motion capture and sensor-based motion capture during baseline, follow up, and each practice session.
Weekly change in baseline foot rotation angle error during stance - at home walking and during practice sessionsBaseline, Weeks 1, 2, 3, 4, 5, 6, 7Foot rotation is the specific walking parameter that will be modified during the intervention. It is defined as the angle between the long axis of the foot and the walking direction. Foot rotation will be measured via sensor-based motion capture over each week of the intervention. Median and inter-quartile ranges will be taken as the primary summary statistic.

Secondary

MeasureTime frameDescription
Change in baseline to week 7 knee joint moment impulseBaseline, Week 7Knee flexion and adduction moment impulses will be calculated. Participants will walk on an instrumented walkway (2 force platforms) while 14 high speed cameras track the trajectories of markers placed on boney landmarks. Moments will be calculated using an inverse dynamics approach.
Change in baseline to week 7 Knee Injury and Osteoarthritis Outcome Score (KOOS)Baseline, Week 7Validated questionnaire on symptoms and functional limitations related to knee osteoarthritis. The score is expressed in percentage (0-100), with 0 representing extreme knee problems and 100 representing no knee problems.
Change in baseline to week 7 knee pain on a numerical rating scaleBaseline, Week 7Knee pain rated on a 0 to 10 scale. 0 = no pain at all and 10 = worst pain imaginable.
Change in week 1 to week 7 difficulty performing the modification on a numerical rating scaleWeek 1, 7Difficulty will be rated on a 0 to 10 scale. 0 = no difficulty at all and 10 = most difficulty imaginable.

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026